Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening-Reference-Cited by-同舟云学术

Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening

Published:2023-04 Issue:16 Volume:41 Page:2634-2644
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Riddle Mark S.^ORCID,Louis Bourgeois A.,Clifford Allison,Jeon Suhi,Giersing Birgitte K.,Jit Mark,Tufet Bayona Marta,Ovitt Jared,Hausdorff William P.

Funder

Bill and Melinda Gates Foundation

Wellcome Trust

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Estimates of the Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoea in 195 Countries: A Systematic Analysis for the Global Burden of Disease Study 2016;Troeger;Lancet Infect Dis,2018

2. Diarrhoeal Disease and Subsequent Risk of Death in Infants and Children Residing in Low-Income and Middle-Income Countries: Analysis of the GEMS Case-Control Study and 12-Month GEMS-1A Follow-on Study;Levine;Lancet Glob Health,2020

3. The Role of Vaccines in Combatting Antimicrobial Resistance;Micoli;Nat Rev Microbiol,2021

4. A Systematic Analysis;Murray;Lancet,2019

5. The Overlooked Pandemic of Antimicrobial Resistance;Laxminarayan;Lancet,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating the development of urgently required combination vaccines;The Lancet Global Health;2024-06

2. Reassessing potential economic value and health impact of effective Shigella vaccines;Bulletin of the World Health Organization;2024-01-01

3. A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions;Microorganisms;2023-12-31

4. Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings;Vaccine: X;2023-12

5. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops;Vaccine;2023-11